This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.

Abstract Details

Activity Number: 645
Type: Invited
Date/Time: Thursday, August 5, 2010 : 10:30 AM to 12:20 PM
Sponsor: Biopharmaceutical Section
Abstract - #306131
Title: Regulatory Considerations for Addressing Multiplicity Problems of Clinical Trials with Multiple Endpoints
Author(s): Mohammad F. Huque*+
Companies: FDA
Address: 10903 New Hampshire Avenue, Silver Spring, MD, 20993-0002,
Keywords: multiplicity ; multiple endpoints ; clinical trials

Confirmatory trials with multiple endpoints can raise multiplicity issues which might impact Type I error. Statistical approaches such as gatekeeping and tree-structured strategies are now available that can solve variety of multiplicity problems for multiple endpoints. However, applications of these approaches in the regulatory setting are often not straightforward as appropriate design and analysis should take into account the peculiarities of different diseases. Therefore, a regulatory guidance is needed. Such guidance would elaborate on basic multiplicity concepts and considerations that can be helpful in making sound regulatory decisions, and are useful in planning of trials and interpretation of results, and also in labeling and promotion of new beneficial treatments. This presentation will provide a list of key topics that can be included in such guidance with some discussions.

The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.

Back to the full JSM 2010 program

2010 JSM Online Program Home

For information, contact or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.